Literature DB >> 3065602

Endocrine myopathies.

R L Ruff1, J Weissmann.   

Abstract

The atrophy produced by endocrine disorders is primarily due to alterations in protein and carbohydrate metabolism. Type II muscle fibers are more severely affected than are Type I fibers. Steroid myopathy and the myopathy associated with excess ACTH have a typical pattern of proximal weakness affecting the legs more than the arms. Steroid myopathy is usually not apparent until other signs of glucocorticoid excess are present. Treatments of steroid myopathy are as follows: Lower the dose of steroid, use a nonfluorinated glucocorticoid, and exercise or physical therapy. Adrenal insufficiency produces generalized weakness, muscle cramping, and fatigue in 50 per cent of patients. Some patients also develop hyperkalemic paralysis. The treatment is hormone replacement. Thyrotoxicosis produces myopathy caused by net protein catabolism, accelerated basal metabolic rate and impaired carbohydrate metabolism. Shortening of contraction time may result from accelerated myosin ATPase activity and enhanced calcium uptake by the sarcoplasmic reticulum. Depolarization of the muscle fiber and impaired Na-K activity in muscle may predispose to thyrotoxic periodic paralysis. Neuromuscular presynaptic impairment may account for the worsening of myasthenia gravis by thyrotoxicosis. In hypothyroidism, impaired energy metabolism may limit force generation. Slow contraction and relaxation reflect reduction in myosin ATPase activity and impaired calcium uptake by the sarcoplasmic reticulum. Treatment for thyroid-associated muscle disorders is restoration of a euthyroid state. Muscle weakness associated with hypopituitarism is due to loss of thyroid and adrenal cortical hormones. Children require growth hormone for muscle development. T3 and growth hormone synergize to maintain normal protein synthesis. Primary and secondary hyperparathyroidism and osteomalacia are often associated with proximal weakness and fatigability. The myopathy improves with restoration of normal PTH levels and vitamin D replacement. Hypoparathyroidism and pseudohypothyroidism are associated with tetany. Tetany is worsened by alkalosis and is treated by calcium and magnesium replacement.

Entities:  

Mesh:

Year:  1988        PMID: 3065602

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  13 in total

1.  A unique ca(u)se of quadriparesis.

Authors:  Sadishkumar Kamalanathan; Karthik Balachandran; Dhanapathi Halanaik; Sarath Chandra
Journal:  BMJ Case Rep       Date:  2012-06-21

Review 2.  Steroid myopathy: some unresolved issues.

Authors:  M A Minetto; F Lanfranco; G Motta; S Allasia; E Arvat; G D'Antona
Journal:  J Endocrinol Invest       Date:  2011-05       Impact factor: 4.256

3.  Reverse remodeling and recovery from cachexia in rats with aldosteronism.

Authors:  Yaser Cheema; Wenyuan Zhao; Tieqiang Zhao; M Usman Khan; Kelly D Green; Robert A Ahokas; Ivan C Gerling; Syamal K Bhattacharya; Karl T Weber
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-06-22       Impact factor: 4.733

4.  An unusual presenting symptom of graves' disease: myalgia.

Authors:  N Papanikolaou; P Perros
Journal:  Eur Thyroid J       Date:  2012-11-15

5.  Molecularly and clinically related drugs and diseases are enriched in phenotypically similar drug-disease pairs.

Authors:  Ingo Vogt; Jeanette Prinz; Mónica Campillos
Journal:  Genome Med       Date:  2014-08-17       Impact factor: 11.117

Review 6.  Corticosteroids in brain cancer patients: benefits and pitfalls.

Authors:  Jörg Dietrich; Krithika Rao; Sandra Pastorino; Santosh Kesari
Journal:  Expert Rev Clin Pharmacol       Date:  2011-03       Impact factor: 5.045

7.  Selective modulation through the glucocorticoid receptor ameliorates muscle pathology in mdx mice.

Authors:  Tony Huynh; Kitipong Uaesoontrachoon; James L Quinn; Kathleen S Tatem; Christopher R Heier; Jack H Van Der Meulen; Qing Yu; Mark Harris; Christopher J Nolan; Guy Haegeman; Miranda D Grounds; Kanneboyina Nagaraju
Journal:  J Pathol       Date:  2013-10       Impact factor: 7.996

8.  Thyroid Hormone Signaling in Muscle Development, Repair and Metabolism.

Authors:  Jang-Won Lee; Nam-Ho Kim; Anna Milanesi
Journal:  J Endocrinol Diabetes Obes       Date:  2014 Jul-Sep

Review 9.  Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications.

Authors:  G Arnaldi; T Mancini; G Tirabassi; L Trementino; M Boscaro
Journal:  J Endocrinol Invest       Date:  2012-04       Impact factor: 4.256

10.  Thyroid Hormone Receptor α Plays an Essential Role in Male Skeletal Muscle Myoblast Proliferation, Differentiation, and Response to Injury.

Authors:  Anna Milanesi; Jang-Won Lee; Nam-Ho Kim; Yan-Yun Liu; An Yang; Sargis Sedrakyan; Andrew Kahng; Vanessa Cervantes; Nikita Tripuraneni; Sheue-yann Cheng; Laura Perin; Gregory A Brent
Journal:  Endocrinology       Date:  2015-10-09       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.